Tracking the Evolving Profile of COVID-19
-
bookmark
-
print
- Keywords:
- covid-19
As North American authorities weigh a reopening of their economies, massive testing will become critical to understanding the evolving profile of infection from COVID-19, Dr. John Whyte, Chief Medical Officer for WebMD, told a BMO Capital Markets conference call this week.
Citing from a report by the Rockefeller Foundation, whose mission is to promote the well-being of humanity throughout the world, Dr. Whyte said testing for the virus will need to be ramped up to some 30 million per week, compared to the 3 million tests done since the outbreak began.
“So testing does remain a critical concern, we really need to ramp-up testing,” said Dr. Whyte, who prior to WebMD served as the Director of Professional Affairs and Stakeholder Engagement at the Center for Drug Evaluation and Research at the USFDA. “Can we get to 30 million a week by June? I'm not sure. But let's start thinking about how we use it on a wider scale,” he said.
Global Toll
Globally there are now over 3 million cases of coronavirus, resulting in over 200,000 deaths.
In Canada, there have been 46,898 cases, with 2,560 deaths, but evidence of recent days has shown the spread of the virus is slowing, with the death toll rising by less than 10 percent per day for the last nine days in a row.
“So we’re really seeing a flattening of the curve, or as some in Canada are saying, planking of the curve,” said Dr. Whyte, “So there’s tremendous progress in Canada in terms of infections and cases.”
In the United States there is also evidence that the spread of the virus has slowed, although figures vary from state to state and even from city to city. As of Monday, the country had reported nearly 1 million cases of COVID-19 infection, with over 55,000 deaths, more than half of them concentrated in the hotspots of New York, New Jersey, Massachusetts, Illinois and California.
Some 40 percent of Americans now say they know someone who has either tested positive for the virus or who think they have had it, and 10 percent say they know someone who has died from complications resulting from coronavirus.
Reopening
“We’re hearing a lot of talk now about reopening,” said Dr. Whyte, pointing at some differences in Canada and the United States. “But the reality is we will likely have some measure of social distancing throughout the summer, probably not what it looks like today. But some measures.”
US Vice-President Michael Pence has said publicly that the virus should be behind us by Memorial Day (May 25).
For any sort of return to normal, Dr. Whyte said, testing will need to become more comprehensive and more efficient, and there are signs of progress being made.
There is now a saliva test to diagnose coronavirus and which health experts believe is as accurate as a nasal swab. Authorities are still learning whether the presence of antibodies in a person’s system means immunity, but Dr. Whyte expects that will be proven out as more data is assessed.
“It’s more likely than not that we develop some sense of immunity after infection,” he said.
Getting Back to Work
Businesses are sufficiently encouraged with declining rates of infection to have begun talking in earnest about what a return to normal might look like, especially with respect to the use of office space. Will offices need to be retrofitted? Will heating and air conditioning need to be reconsidered? Should businesses look at how to time-shift people's work in the office?
Just as important as turning to science to protect people’s physical health, is the mental health of individuals, and making sure they feel safe in returning to their jobs and daily routines, Dr. Whyte said.
“I'm optimistic that we're sorting out a strategy to reopening. We're talking about it from a scientific, risk-based approach.”
John Whyte, MD, MPH, is a popular physician and writer who has been communicating to the public about health issues for nearly two decades. Whyte is th…(..)
View Full Profile >As North American authorities weigh a reopening of their economies, massive testing will become critical to understanding the evolving profile of infection from COVID-19, Dr. John Whyte, Chief Medical Officer for WebMD, told a BMO Capital Markets conference call this week.
Citing from a report by the Rockefeller Foundation, whose mission is to promote the well-being of humanity throughout the world, Dr. Whyte said testing for the virus will need to be ramped up to some 30 million per week, compared to the 3 million tests done since the outbreak began.
“So testing does remain a critical concern, we really need to ramp-up testing,” said Dr. Whyte, who prior to WebMD served as the Director of Professional Affairs and Stakeholder Engagement at the Center for Drug Evaluation and Research at the USFDA. “Can we get to 30 million a week by June? I'm not sure. But let's start thinking about how we use it on a wider scale,” he said.
Global Toll
Globally there are now over 3 million cases of coronavirus, resulting in over 200,000 deaths.
In Canada, there have been 46,898 cases, with 2,560 deaths, but evidence of recent days has shown the spread of the virus is slowing, with the death toll rising by less than 10 percent per day for the last nine days in a row.
“So we’re really seeing a flattening of the curve, or as some in Canada are saying, planking of the curve,” said Dr. Whyte, “So there’s tremendous progress in Canada in terms of infections and cases.”
In the United States there is also evidence that the spread of the virus has slowed, although figures vary from state to state and even from city to city. As of Monday, the country had reported nearly 1 million cases of COVID-19 infection, with over 55,000 deaths, more than half of them concentrated in the hotspots of New York, New Jersey, Massachusetts, Illinois and California.
Some 40 percent of Americans now say they know someone who has either tested positive for the virus or who think they have had it, and 10 percent say they know someone who has died from complications resulting from coronavirus.
Reopening
“We’re hearing a lot of talk now about reopening,” said Dr. Whyte, pointing at some differences in Canada and the United States. “But the reality is we will likely have some measure of social distancing throughout the summer, probably not what it looks like today. But some measures.”
US Vice-President Michael Pence has said publicly that the virus should be behind us by Memorial Day (May 25).
For any sort of return to normal, Dr. Whyte said, testing will need to become more comprehensive and more efficient, and there are signs of progress being made.
There is now a saliva test to diagnose coronavirus and which health experts believe is as accurate as a nasal swab. Authorities are still learning whether the presence of antibodies in a person’s system means immunity, but Dr. Whyte expects that will be proven out as more data is assessed.
“It’s more likely than not that we develop some sense of immunity after infection,” he said.
Getting Back to Work
Businesses are sufficiently encouraged with declining rates of infection to have begun talking in earnest about what a return to normal might look like, especially with respect to the use of office space. Will offices need to be retrofitted? Will heating and air conditioning need to be reconsidered? Should businesses look at how to time-shift people's work in the office?
Just as important as turning to science to protect people’s physical health, is the mental health of individuals, and making sure they feel safe in returning to their jobs and daily routines, Dr. Whyte said.
“I'm optimistic that we're sorting out a strategy to reopening. We're talking about it from a scientific, risk-based approach.”
What to Read Next.
Uncertainty Rules
Sal Guatieri | November 09, 2020 | Economic Insights, Addressing Covid 19
Assuming President-elect Joe Biden is inaugurated on January 20 (following legal challenges from the Trump administration and potential recounts) and…
Continue Reading>Related Insights
Tell us three simple things to
customize your experience
Banking products are subject to approval and are provided in Canada by Bank of Montreal, a CDIC Member.
BMO Commercial Bank is a trade name used in Canada by Bank of Montreal, a CDIC member.
Please note important disclosures for content produced by BMO Capital Markets. BMO Capital Markets Regulatory | BMOCMC Fixed Income Commentary Disclosure | BMOCMC FICC Macro Strategy Commentary Disclosure | Research Disclosure Statements
BMO Capital Markets is a trade name used by BMO Financial Group for the wholesale banking businesses of Bank of Montreal, BMO Bank N.A. (member FDIC), Bank of Montreal Europe p.l.c., and Bank of Montreal (China) Co. Ltd, the institutional broker dealer business of BMO Capital Markets Corp. (Member FINRA and SIPC) and the agency broker dealer business of Clearpool Execution Services, LLC (Member FINRA and SIPC) in the U.S. , and the institutional broker dealer businesses of BMO Nesbitt Burns Inc. (Member Canadian Investment Regulatory Organization and Member Canadian Investor Protection Fund) in Canada and Asia, Bank of Montreal Europe p.l.c. (authorised and regulated by the Central Bank of Ireland) in Europe and BMO Capital Markets Limited (authorised and regulated by the Financial Conduct Authority) in the UK and Australia and carbon credit origination, sustainability advisory services and environmental solutions provided by Bank of Montreal, BMO Radicle Inc., and Carbon Farmers Australia Pty Ltd. (ACN 136 799 221 AFSL 430135) in Australia. "Nesbitt Burns" is a registered trademark of BMO Nesbitt Burns Inc, used under license. "BMO Capital Markets" is a trademark of Bank of Montreal, used under license. "BMO (M-Bar roundel symbol)" is a registered trademark of Bank of Montreal, used under license.
® Registered trademark of Bank of Montreal in the United States, Canada and elsewhere.
™ Trademark of Bank of Montreal in the United States and Canada.
The material contained in articles posted on this website is intended as a general market commentary. The opinions, estimates and projections, if any, contained in these articles are those of the authors and may differ from those of other BMO Commercial Bank employees and affiliates. BMO Commercial Bank endeavors to ensure that the contents have been compiled or derived from sources that it believes to be reliable and which it believes contain information and opinions which are accurate and complete. However, the authors and BMO Commercial Bank take no responsibility for any errors or omissions and do not guarantee their accuracy or completeness. These articles are for informational purposes only.
Bank of Montreal and its affiliates do not provide tax, legal or accounting advice. This material has been prepared for informational purposes only, and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. You should consult your own tax, legal and accounting advisors before engaging in any transaction.
Third party web sites may have privacy and security policies different from BMO. Links to other web sites do not imply the endorsement or approval of such web sites. Please review the privacy and security policies of web sites reached through links from BMO web sites.
Please note important disclosures for content produced by BMO Capital Markets. BMO Capital Markets Regulatory | BMOCMC Fixed Income Commentary Disclosure | BMOCMC FICC Macro Strategy Commentary Disclosure | Research Disclosure Statements